A Phase III Study to Efficacy and Safety of DWC202405/DWC202313 and DWC202314 in Patients With Hypertension
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 198 participants.
Also called NCT06671392
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 198 participants
- Registry
-
NCT06671392
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT06671392. Randomized; double masking; primary purpose treatment. Start 2025-02-24 (actual); primary completion 2026-02-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Phase III Study to Efficacy and Safety of DWC202405/DWC202313 and DWC202314 in Patients With Hypertension
- Condition
- Essential Hypertension
- Intervention (Drug)
- DWC202405
- Intervention (Drug)
- DWC202405, DWC202314
- Intervention (Drug)
- DWC202405, DWC202314P
- Intervention (Drug)
- DWC202313, DWC202314
- Intervention (Drug)
- DWC202313, DWC202314P
- Lead sponsor
- Daewoong Pharmaceutical Co. LTD.
Record details
- Record id
cardio:ct-nct06671392- Content hash
f50009ee05cbe1a1dbe6936561845f55526890757996c9e781cd848e841fe6b7